Buy @$10, Sell at $15+: Big Dip Opportunity!I wasn't able to get into $VXRT before, and now thanks to a recent market overreaction, I think this is a great dip opportunity and will pickup support levels that will cause a short squeeze soon. RSI shows way oversold, and look at the performance day to day. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
Stockpicks
Acquires Exclusive Rights to Rare Earth Element InnovationsAmerican Resources Corporation Acquires Exclusive Rights to Purdue University's Rare Earth Element Innovations, Critical for Clean Energy Technologies.
An environmentally safer method of rare earth and other critical material separation and purification using ligand-assisted chromatography for coal, coal byproducts, recycled permanent magnets and Lithium Ion batteries.
Announced that, with the addition of Hasler Ventures LLC, the Company has licensed ligand assisted displacement ("LAD") chromatography patents and knowhow to further expanded its capability in environmentally friendly separation and purification of rare earth elements.
These exclusive patents and technologies, developed at Purdue University, are specific to the processing of separated and pure rare earth metals and critical elements from coal byproducts, recycled permanent magnets and lithium-ion batteries.
Rare earth elements (REEs) include the 15 elements in the lanthanide series plus scandium (Sc) and yttrium (Y). They are essential ingredients for magnets, metal alloys, polishing powders, catalysts, ceramics, and phosphors, which are important for high-technology and clean energy applications. The global REE market is estimated at approximately $4 billion dollars and growing at 8% per year.
finance.yahoo.com
$FLYY Cup formation in playWe will see .07 for the cup and then the handle will rocket the price. Exciting!!
$BFT Continued Uptrend: TP #1: $25+A special acquisition for a PayPal competitor that has way less of a marketcap, but way higher of a TAM and growth potential opportunity. Sort of reminds me of the $JMIA play in regards to $BABA. Pattern is on an uptrend as well w/ continued support levels and likely positive sentiment. That said, do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
High Risk, but can $GME hit $500+Gamestop was one of those chances that I missed just like SPI. There was no way to tell what happened on Reddit was going to happen. However, given the continued sentiment (even w/ red futures), it may be possible to pickup even higher support levels and continue the trend up to $500. If one wants to do risk mitigation if the price falls, going covered to make money either way and trying to allocate on timing is the best risk management + profit strategy. That said, $GME is currently a high risk trade. I do think though it is interesting to see the little guys winning, and I am a big fan of free trade. Let the traders, trade! That said, please keep in mind everything I say is on an opinion based basis. Invest at your own risk and do your own due diligence.
Latch to Merge with TSIA SPAC and Become Publicly Listed CompanyLatch, Maker of Full-Building Enterprise SaaS Platform LatchOS, to Merge with Tishman Speyer-Sponsored SPAC and Become Publicly Listed Company
Provides Capital to Accelerate Latch's Expansion and Drive Enhanced Growth; More Than One-in-Ten New Apartments in the U.S. Built with LatchOS in 2019
Latch to Have up to $510 Million in Cash, Including $190 Million in PIPE Investments Anchored by Funds and Accounts Managed by BlackRock, D1 Capital Partners, Durable Capital Partners LP, Fidelity Management & Research Company LLC, Chamath Palihapitiya, The Spruce House Partnership, Wellington Management, ArrowMark Partners, Avenir and Lux Capital
-- Transaction Values Latch at Equity Value of $1.56 Billion Post-Money
The Company has booked over 300,000 units across more than 35 states, with one in ten new multifamily apartments in the United States built with Latch in 2019.
"Latch has successfully created an entire ecosystem around our full building operating system, devices, and partners that enhances the building experience for both owners and residents,"
The Company has generated strong results to date, including $167 million in Booked Revenue1 in 2020, which represents 49 percent growth from 2019; zero customer churn leading to 100 percent Gross Revenue Retention2; and a strong SaaS company Lifetime Value (LTV) to Customer Acquisition Costs (CAC) ratio of 6.8x3.
The transaction, which has been unanimously approved by TSIA's board of directors, is expected to close in the second quarter of 2021.
finance.yahoo.com
Sunlight Financial LLC to List on NYSE Through Merger With SPRQSunlight Financial LLC, a Premier Residential Solar Financing Platform, to List on NYSE Through Merger With Apollo-Affiliated Spartan Acquisition Corp. II
Sunlight and Apollo-Affiliated Spartan Acquisition Corp. II (NYSE: SPRQ) Enter Into Business Combination Agreement
Institutional Investors Led By Chamath Palihapitiya, Coatue, Funds and Accounts Managed by BlackRock, Franklin Templeton and Neuberger Berman Commit to Invest $250 Million at Closing in Common Stock PIPE at $10.00 per Share
Pro Forma Implied Equity Value of the Combined Company is Approximately $1.3 Billion
Sunlight has arranged financing for more than an estimated 100,000 residential solar systems, which will produce over 500 megawatts of solar-generated electricity and avoid more than 10 million metric tons of carbon dioxide emissions.
Leading POS platform through which over $3.5 billion of loans have been originated in the rapidly growing residential solar market
Upon the closing of the transaction, existing Sunlight equityholders are expected to own approximately 50% of the combined company, Spartan stockholders are expected to own approximately 26%, and PIPE participants are expected to own approximately 19%.
The transaction is expected to close in the second quarter of 2021.
finance.yahoo.com
ET Technical Analysis 🧙Energy Transfer owns a large platform of crude oil, natural gas, and natural gas liquid assets primarily in Texas and the U.S. midcontinent region. Its pipeline network transports about 22 trillion British thermal unit per day of natural gas and 4.3 million barrels per day of crude oil. It also has gathering and processing facilities, one of the largest fractionation facilities in the U.S., and fuel distribution. Energy Transfer also owns the Lake Charles gas liquefaction facility, which it plans to convert into one of the largest LNG export facilities. It combined its publicly traded limited and general partnerships in October 2018.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
APTO Technical Analysis 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
This Penny Stock NMTR Could soar 462% in 2021The company’s development pipeline features drug candidates under investigation as treatments for short bowel syndrome (SBS) and celiac disease (CeD), two conditions that are both dangerous and difficult to treat.
9 Meters’ flagship product, Larazotide, is in Phase 3 development for the treatment of CeD. CeD affects about 1% of the population, yet there are no approved therapies. Top-line data from the study is expected in the second half of 2021.
Furthermore, this past December, the company announced that it had entered an agreement with EBRIS, the European Biomedical Research Institute of Salerno, to investigate Larazotide as a potential treatment for respiratory complications due to COVID-19.
The other major drug in the company’s pipeline is NM-002, for SBS. The company has recently announced positive Phase 1b/2a results, with a measurable impact on disease symptoms from a compound that was well-tolerated by patients.
ne of these NMTR bulls is Truist’s Srikripa Devarakonda. Citing Larazotide as a key component of his bullish thesis, the analyst noted, “We acknowledge investors are likely to see a pivotal trial in a tough-to-crack Celiac disease program as high risk despite encouraging Ph2b data. We model $705M/$353M in peak unadjusted/adjusted sales and see potential upside of 400% - 1650% from positive Ph3 readout.”
finance.yahoo.com
TOP WSB PLAYS: $GME $AMC $NOK $EXPR $PHUN $NAKDHistory in the making...
$AMC Jan 21st 2022 $40 Calls
$NOK Jan 21st 2022 $17 Calls
Returns +155,000%
12 Mid-High Risk Stocks in my 2021 WatchlistThe 12 mid to high risk stocks in my 2021 watchlist include: $ATOM, $ADOM, $NNDM, $BNGO, $PUBM, $UPWK, $BLSP, $RETC, $LGVW, $PSAC, $HYLN, and $NETE. Currently, the ones that excite me the most are: $NNDM, $LGVW, $BLSP, $ATOM and $HYLN. I am also keeping a close watch on the $PSAC spac, which I believe is Faraday Futures. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.